Cite
HARVARD Citation
Ren, L. et al. (2021). The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway. Bioengineered. 12 (1), pp. 5985-5995. [Online].